Sort
261,768 grants matching “gene therapy”
Development and application of transposable element technology
$1,196,104Henry L. Levin · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD
Targeting vulnerabilities of therapy-resistant cancer cell states with small molecules
$1,196,074Stuart L Schreiber · Broad Institute, Inc. · U01 · FY2020 · CA
Targeting vulnerabilities of therapy-resistant cancer cell states with small molecules
$1,196,073Stuart L Schreiber · Broad Institute, Inc. · U01 · FY2021 · CA
Epigenetic strategies for the in vitro generation of replacement beta cells
$1,196,058Maike Sander · University Of California, San Diego · U01 · FY2012 · DK
Gene Therapy for Urea Cycle Disorders
$1,196,049James M Wilson · University Of Pennsylvania · P01 · FY2012 · HD
Long-Acting G-CSF Analog for Treating ARS
$1,196,000George Norbert Cox · Bolder Biotechnology, Inc. · R44 · FY2015 · AI
Development of Gene-Silencing Therapeutics for Pseudomonas aeruginosa
$1,195,983David Elihu Greenberg · Ut Southwestern Medical Center · R01 · FY2024 · AI
Engineered HSV for Treatment of Malignant Gliomas
$1,195,836University Of Alabama At Birmingham · P01 · FY2004 · CA
NSF/MCB-BSF: Sentinels: Viral First Responder Cells (VFRCs) for COVID-19 and Future Rapidly Emerging Infectious Diseases
$1,195,831Ron Weiss · Massachusetts Institute Of Technology · · FY2021 · BIO
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,195,794Mark Connors · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Molecular Genetics Of Heritable Human Disorders
$1,195,691Janice Chou · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2012 · HD
Impact of sex differences on the trajectory of interactome dysfunctions across the AD spectrum
$1,195,676Gabriela Chiosis · Sloan-Kettering Inst Can Research · R01 · FY2022 · AG
Driving Medical Projects (4 of 4)
$1,195,593Edward Mark Scolnick · Broad Institute, Inc. · RL1 · FY2011 · GM
Genetic and Environmental Modifiers Of Autoimmune Disease
$1,195,579Silvia Bolland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Promoting T cell reconstitution after hematopoietic cell transplantation
$1,195,546Jarrod Dudakov · Fred Hutchinson Cancer Center · R35 · FY2024 · HL
Promoting T cell reconstitution after hematopoietic cell transplantation
$1,195,546Jarrod Dudakov · Fred Hutchinson Cancer Center · R35 · FY2025 · HL
Microenvironmental control of progenitors in organ dysfunction and repair
$1,195,425Jay W Schneider · Ut Southwestern Medical Center · U01 · FY2012 · HL
Epigenetic strategies for the in vitro generation of replacement beta cells
$1,195,258Maike Sander · University Of California, San Diego · U01 · FY2011 · DK
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform
$1,195,189Shawn Hingtgen · Univ Of North Carolina Chapel Hill · U01 · FY2021 · TR
Genetic Susceptibility and Biomarkers of Platinum-related Toxicities
$1,195,158Lois B. Travis · Indiana University Indianapolis · R01 · FY2020 · CA
More Complete Assessment of DNA Variation in Age-Related Macular Degeneration
$1,195,139Goncalo Rocha Abecasis · University Of Michigan At Ann Arbor · R01 · FY2011 · EY
SCOR IN MOLECULAR MEDICINE AND ATHEROSCLEROSIS
$1,195,100Weill Medical College Of Cornell Univ · P50 · FY2000 · HL
Restoration of free radical homeostasis: novel therapy of septic shock
$1,194,948Andrew L Salzman · Radikal Therapeutics, Inc. · R44 · FY2017 · GM
RELEVANCE OF GENOMIC ALTERATIONS IN COLORECTAL CANCER
$1,194,918Thomas Jefferson University · P01 · FY2004 · CA
GrowthDifferentiation Factors in Organogenesis
$1,194,902Alan Perantoni · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA